Search - tctmd.com

Displaying 21 - 40 of 167

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

The Venus A-Valve and Venibri TAVR Systems: Better for Bicuspids and Dry Leaflet Technology

Presenter: Horst Sievert

June 22, 2018

The ACCURATE NEO TAVR System: Illustrative Cases (Eg, Horizontal Aorta)

Presentation The Structural Heart Disease Summit 2018

The ACURATE NEO TAVR System: Illustrative Cases (Eg, Horizontal Aorta)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presenter: Michael J. Mack, Raj Makkar

June 22, 2018

Program Update: The ACCURATE NEO TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presentation The Structural Heart Disease Summit 2018

Program Update: The ACURATE NEO TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Alexandre Abizaid

June 22, 2018

$Aortic Watchman As Centinel for Thrombus Embolization in Patient With Recurrent Lower Gastrointestinal Bleeding and Refractory Thrombus in LAA$

Presentation The Structural Heart Disease Summit 2018

Aortic Watchman As Centinel for Thrombus Embolization in Patient With Recurrent Lower Gastrointestinal Bleeding and Refractory Thrombus in LAA

Presenter: Horst Sievert, Robert J. Sommer, Luis Gutierrez, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presenter: Michael J. Mack, Raj Makkar, Maria Alu, MS

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The PORTICO TAVR System: Illustrative Cases (Eg, Low Coronaries)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Minimizing Left Ventricular Outflow Tract Obstruction in Valve-in-Mitral Cases: A Novel Technique

Presenter: Juan F. Granada, Martin B. Leon, Tarek Helmy

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presenter: Michael J. Mack, Raj Makkar, Lars Sondergaard

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Program Update: The PORTICO TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Raj Makkar

June 22, 2018

The LOTUS TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presentation The Structural Heart Disease Summit 2018

The LOTUS Edge TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The LOTUS Edge TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR to Treat Pure Aortic Regurgitation: Published and Personal Experiences (With Case Examples)

Presenter: Howard C. Herrmann, Allan Schwartz, Eberhard Grube

June 22, 2018

Program Update: The LOTUS TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presentation The Structural Heart Disease Summit 2018

Program Update: The LOTUS Edge TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Ted Feldman

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset

Presenter: Howard C. Herrmann, Allan Schwartz, Jonathan Afilalo

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

Presenter: Francesco Maisano

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders?

Presenter: Howard C. Herrmann, Allan Schwartz, Suzanne V. Arnold

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device: The SAFE MANTA Study

Presenter: David A. Wood

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Conductor (Illustrative Cases)

Presenter: Tamim Nazif

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS

Presenter: Howard C. Herrmann, Allan Schwartz

June 22, 2018

Advertisement

The Venus A-Valve and Venibri TAVR Systems: Better for Bicuspids and Dry Leaflet Technology

The ACURATE NEO TAVR System: Illustrative Cases (Eg, Horizontal Aorta)

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Program Update: The ACURATE NEO TAVR System - Design Characteristics, Clinical Data, and Future Vision

Aortic Watchman As Centinel for Thrombus Embolization in Patient With Recurrent Lower Gastrointestinal Bleeding and Refractory Thrombus in LAA

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

The PORTICO TAVR System: Illustrative Cases (Eg, Low Coronaries)

Minimizing Left Ventricular Outflow Tract Obstruction in Valve-in-Mitral Cases: A Novel Technique

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Program Update: The PORTICO TAVR System - Design Characteristics, Clinical Data, and Future Vision

The LOTUS Edge TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

The LOTUS Edge TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

TAVR to Treat Pure Aortic Regurgitation: Published and Personal Experiences (With Case Examples)

Program Update: The LOTUS Edge TAVR System: Design Characteristics, Clinical Data, and Future Vision

Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset

Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders?

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device: The SAFE MANTA Study

Conductor (Illustrative Cases)

CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content